Endovascular therapy, a minimally invasive surgery performed inside the blood vessels, is preferred to alternative approaches for vessel obstructions in life-sustaining areas of the brain, analysis suggests.

A groundbreaking new database could lead to vast improvements in precision oncology by documenting sex-based differences in cancer treatment efficacy, biomarkers, risk factors, and microbial influences across 71 cancer types. The database — created by researchers at the Yale School of Public Health (YSPH), Yale School of Medicine (YSM), and international collaborators — addresses a significant gap in current research and demonstrates how biological sex can comprehensively impact cancer onset, progression, and therapeutic outcomes, the researchers said.

The project, which the researchers call OncoSexome, was created in response to the tendency of scientists and clinicians to overlook sex differences in clinical trials.